BCM
Bayesian Capital Management’s Novavax NVAX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,500
| Closed | -$330K | – | 772 |
|
|
2025
Q1 | $330K | Buy |
+51,500
| New | +$330K | 0.05% | 370 |
|
|
2024
Q3 | – | Sell |
-25,200
| Closed | -$319K | – | 940 |
|
|
2024
Q2 | $319K | Buy |
+25,200
| New | +$319K | 0.04% | 490 |
|
|
2023
Q4 | – | Sell |
-83,300
| Closed | -$603K | – | 948 |
|
|
2023
Q3 | $603K | Buy |
83,300
+55,200
| +196% | +$400K | 0.07% | 335 |
|
|
2023
Q2 | $209K | Buy |
+28,100
| New | +$209K | 0.02% | 632 |
|
|
2022
Q3 | – | Sell |
-15,374
| Closed | -$791K | – | 926 |
|
|
2022
Q2 | $791K | Sell |
15,374
-14,009
| -48% | -$721K | 0.15% | 209 |
|
|
2022
Q1 | $2.16M | Buy |
+29,383
| New | +$2.16M | 0.32% | 58 |
|
|
2021
Q4 | – | Sell |
-4,846
| Closed | -$1.01M | – | 477 |
|
|
2021
Q3 | $1.01M | Buy |
+4,846
| New | +$1.01M | 0.29% | 89 |
|
|
2020
Q4 | – | Sell |
-13,400
| Closed | -$1.45M | – | 613 |
|
|
2020
Q3 | $1.45M | Buy |
+13,400
| New | +$1.45M | 0.35% | 69 |
|
|
2019
Q1 | – | Sell |
-22,600
| Closed | -$42K | – | 694 |
|
|
2018
Q4 | $42K | Buy |
+22,600
| New | +$42K | 0.01% | 582 |
|
|
2017
Q3 | – | Sell |
-22,900
| Closed | -$26K | – | 597 |
|
|
2017
Q2 | $26K | Buy |
+22,900
| New | +$26K | 0.01% | 399 |
|